Literature DB >> 17361257

Role of inflammation in retinal vein occlusion.

H B Harold Lee1, Jose S Pulido, Colin A McCannel, Helmut Buettner.   

Abstract

BACKGROUND: Inflammation measured by using highly sensitive C-reactive protein (hs-CRP) may be a separate risk factor in retinal vein occlusion (RVO).
METHODS: In a small consecutive pilot case series, hs-CRP was measured in 11 patients with RVO.
RESULTS: Levels ranged from 1.0 to 18.0 mg/L (mean 6.5 [SD 6.1] mg/L), with >3.0 mg/L being considered high risk for developing vascular disease.
INTERPRETATION: The new role of hs-CRP is important for ophthalmologists because of its part in vascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361257     DOI: 10.1139/i06-101

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  9 in total

1.  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).

Authors:  Baruch D Kuppermann; Leandro Cabral Zacharias; M Cristina Kenney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

2.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.

Authors:  Michael S Ip; Ingrid U Scott; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Lawrence J Singerman; Michael Tolentino; Clement K Chan; Victor H Gonzalez
Journal:  Arch Ophthalmol       Date:  2009-09

3.  The predictive value of retinal vascular findings for carotid artery atherosclerosis: are further recommendations with regard to carotid atherosclerosis screening needed?

Authors:  Yeo-Jeong Song; Kyoung-Im Cho; Seong-Man Kim; Hyun-Duk Jang; Jung-Min Park; Sang-Soo Kim; Dong-Jun Kim; Hyeon-Gook Lee; Tae-Ik Kim
Journal:  Heart Vessels       Date:  2012-06-09       Impact factor: 2.037

4.  Evaluation of Systemic Endothelial Dysfunction in Retinal Vein Occlusions.

Authors:  Erdinc Bozkurt; Turkhun Cetin; Ibrahim Rencuzogullari
Journal:  Beyoglu Eye J       Date:  2022-05-27

5.  Effect of posterior sub-tenon triamcinolone in macular edema due to non-ischemic vein occlusions.

Authors:  Murali Mohan Gurram
Journal:  J Clin Diagn Res       Date:  2013-09-13

6.  A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.

Authors:  Ingrid U Scott; Michael S Ip; Paul C VanVeldhuisen; Neal L Oden; Barbara A Blodi; Marian Fisher; Clement K Chan; Victor H Gonzalez; Lawrence J Singerman; Michael Tolentino
Journal:  Arch Ophthalmol       Date:  2009-09

7.  Evaluation of pattern electroretinogram in retinal vein occlusion treated with intravitreal triamcinolone acetonide.

Authors:  Jawahar Lal Goyal; Richa Agarwal; Ritu Arora; Pooja Jain; Basudeb Ghosh
Journal:  Doc Ophthalmol       Date:  2016-04-04       Impact factor: 2.379

Review 8.  Management of retinal vascular diseases: a patient-centric approach.

Authors:  C S Brand
Journal:  Eye (Lond)       Date:  2012-04       Impact factor: 3.775

9.  Elevated plasma pentraxin 3 and its association with retinal vein occlusion.

Authors:  Kyung Soo Park; Ji Wan Kim; Jae Hwan An; Je Moon Woo
Journal:  Korean J Ophthalmol       Date:  2014-11-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.